Evaluation of Thermocool SF Catheter on the Common Cavo-tricuspid Isthmus Dependent Atrial Flutter Ablation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 150 participants.

Also called NCT02698592

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02698592
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02698592. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Thermocool SF Catheter on the Common Cavo-tricuspid Isthmus Dependent Atrial Flutter Ablation
Condition
Atrial Flutter.
Intervention (Device)
CelsiusTMDS® 8 mm catheter
Intervention (Device)
Thermocool® 3.5 mm catheter of irrigated tip
Intervention (Device)
Thermocool® SF catheter
Lead sponsor
Hospital Universitario Central de Asturias (class: other)
Collaborator
Johnson & Johnson (class: industry)

Record details

Record id
cardio:ct-nct02698592
Content hash
f4d2da267baaa757747141772c2c27f07bfc94c17ac88d8e08f36d6a95bc21d1